Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia
T Poliakova, CL Wellington - Molecular neurodegeneration, 2023 - Springer
This narrative review focuses on the role of cholesteryl ester transfer protein (CETP) and
peripheral lipoproteins in the vascular contributions to cognitive impairment and dementia …
peripheral lipoproteins in the vascular contributions to cognitive impairment and dementia …
[HTML][HTML] The pleiotropic effects of lipid-modifying interventions: exploring traditional and emerging hypolipidemic therapies
D Kounatidis, N Tentolouris, NG Vallianou, I Mourouzis… - Metabolites, 2024 - mdpi.com
Atherosclerotic cardiovascular disease poses a significant global health issue, with
dyslipidemia standing out as a major risk factor. In recent decades, lipid-lowering therapies …
dyslipidemia standing out as a major risk factor. In recent decades, lipid-lowering therapies …
Cholesteryl ester transfer protein inhibition: a pathway to reducing risk of morbidity and promoting longevity
MH Davidson, A Hsieh… - Current Opinion in …, 2024 - journals.lww.com
At present, there is robust clinical evidence to support the benefits of reducing CETP activity
for ASCVD risk reduction, and plausibility exists for the promotion of longevity by reducing …
for ASCVD risk reduction, and plausibility exists for the promotion of longevity by reducing …
Reducing CETP activity prevents memory decline in an Alzheimer′ s disease mouse model
J Phénix, I Sarty, MS Katz, H Nie, A Kerksiek, RS Kiss… - bioRxiv, 2024 - biorxiv.org
Epidemiological studies have shown that lower activity of the cholesteryl ester transfer
protein (CETP) correlates with reduced Alzheimer′ s disease (AD) risk. While small …
protein (CETP) correlates with reduced Alzheimer′ s disease (AD) risk. While small …